![]() |
市場調查報告書
商品編碼
1378014
葡萄糖酸鈣市場:2023-2028 年預測Calcium Gluconate Market - Forecasts from 2023 to 2028 |
葡萄糖酸鈣是一種用石灰或碳酸鈣中和葡萄糖酸製成的礦物質補充劑。葡萄糖酸鈣可用於治療低鈣手足抽搐、低血壓、副甲狀腺功能亢進引起的副甲狀腺機能亢進症、快速生長或懷孕引起的低血鈣、高鎂血症等,採用靜脈療法等,有助於於治療因缺乏鈣引起的疾病。由於藥品、食品和飲料等最終用途產品的需求不斷增加,葡萄糖酸鈣市場預計將在全球擴張。
參與企業在葡萄糖酸鈣市場的投資將致力於獲取新技術、獲取原料、有效的採購和庫存管理、改進產品系列以及即使在困難的經濟狀況下也能利用技能來維持成長。由於不同市場和國家的經濟和社會障礙差異很大,葡萄糖酸鈣製造商和相關企業正在專注於制定針對特定國家的策略。
乳酸葡萄糖酸鈣是一種白色結晶質粉末,無味、無臭。它具有生理相容性且無毒性。葡萄糖酸乳酸鈣具有優異的生物利用度、中性味道、良好的溶解度。在醫學上,它被用作高級鈣源。對人體研究的科學分析表明,乳酸葡萄糖酸鈣始終比其他鈣鹽更顯著地增加骨骼密度。乳酸鈣主要用於低溫食品加工、生產線混合以及溶解度敏感問題的其他應用,例如透明飲料和濃縮/快速製劑。這些是葡萄糖酸鈣市場的主要促進因素。
按應用細分葡萄糖酸鈣市場,製藥業佔最大佔有率。由於生活方式的改變和缺乏鍛煉,對骨質疏鬆症藥物的需求增加正在推動市場。推動葡萄糖酸鈣市場的另一個因素是由於繁忙的工作日程而對冷凍和去皮蔬菜的需求不斷成長。消費者對預防缺鈣產品的需求顯著增加,推動了葡萄糖酸鈣市場的發展。
北美地區醫療保健產業的擴張是該地區葡萄糖酸鈣市場的主要促進因素。治療甲狀腺疾病和佝僂病的藥物生產以及強生和輝瑞等多家製造商在該地區的存在是推動葡萄糖酸鈣市場成長的因素。由於該地區食品和飲料行業的擴張,預計亞太地區在預測期內將以最高的成長率發展。由於健康意識的提高,對生產營養豐富的食品的需求不斷增加,預計該地區的葡萄糖酸鈣市場將會成長。
我們於 2021 年 4 月與兒童投資基金基金會、紐約科學院營養科學計畫合作推出了鈣任務小組。該計劃的主要目標是解決全球缺鈣及其對健康的影響、鈣狀態指標以及孕產婦供給以改善懷孕結果。經常建議供給鈣,例如葡萄糖酸鈣,以維持心血管健康。這是因為研究表明,鈣水平較低與心血管疾病風險增加之間存在潛在關聯。由於心臟病死亡人數不斷增加,葡萄糖酸鈣的市場佔有率將會增加。
Calcium gluconate is a mineral supplement that can be made by neutralizing gluconic acid with lime or calcium carbonate. Using intravenous therapy (IV) and other ways, calcium gluconate aids in the treatment of illnesses brought on by calcium shortages, such as hypocalcemia tetany, hypotension, hypocalcemia linked to hyperparathyroidism, hypocalcemia brought on by fast growth or pregnancy, and hypermagnesemia. The calcium gluconate market is expected to expand globally due to rising demand for end-use products, including medicines, and food & beverages.
Investments made by participants in the calcium gluconate market will go towards acquiring new technologies, obtaining raw materials, effective procurement and inventory management, improving product portfolios, and using skills to sustain growth in difficult economic times. Manufacturers of calcium gluconate and related firms are concentrating on developing country-specific strategies since the economic and social obstacles vary greatly between various markets and nations.
Calcium lactate gluconate is a powder that is white, crystalline, tasteless, and odorless. It has high physiological compatibility and is non-toxic. Calcium lactate gluconate has excellent bioavailability, a neutral taste, and excellent solubility. In medicines, it serves as a premium calcium source. According to scientific analyses of human research, calcium lactate gluconate increases bone mineral density more consistently and significantly than other calcium salts. It is mostly used in food processing at low temperatures, in line blending, and other applications where solubility is a delicate issue, such as clear drinks and concentrated or quick preparations. This is the main driving factor for the calcium gluconate market.
The pharmaceutical industry accounted for the largest share of the calcium gluconate market when segmented by application due to its advantages in medical treatment. The increased demand for osteoporosis medicines is driving the market due to the changing lifestyle and inactivity. Another factor driving the calcium gluconate market is the rising demand for frozen and peeled veggies due to hectic work schedules. There has been a significant rise in consumer demand for calcium deficiency prevention products, propelling the calcium gluconate market.
Expanding the local healthcare sector in North America is the main driver for the calcium gluconate market in the region. The production of medications for treating thyroid problems and rickets, as well as the presence of multiple manufacturers in the area, including Johnson & Johnson and Pfizer Inc., are factors propelling the calcium gluconate market growth. While due to the expanding regional food & beverage sector, Asia-Pacific is anticipated to develop at the greatest growth rate throughout the projection period. As the demand for the manufacturing of nutrient-dense foods increases with growing health awareness, the calcium gluconate market is anticipated to rise in the region.
In collaboration with the Children's Investment Fund Foundation, the Nutrition Science Programme of the New York Academy of Sciences, they launched a calcium task group in April 2021. This program's major objective was to address worldwide calcium shortage and its effects on health, calcium status indicators, and calcium supplementation for expectant mothers to enhance pregnancy outcomes. Calcium supplementation, such as calcium gluconate, is frequently advised to maintain cardiovascular health since studies have revealed a potential relationship between low calcium levels and an increased risk of cardiovascular disorders. The calcium gluconate market share will increase due to the rise in heart disease fatalities.